Saturday, December 13, 2008
Kidney Stones - Useful Treatments For the Sufferers of Kidney Stones
Kidney stones treatment can typically be run with no surgical procedure. Drinking water is the most essential point in assisting to cut growth. Treatment for it is important for a sufferer. Those who have never passed a kidney stone may not realize the seriousness of the symptoms. There is not a lot a person can execute with unbearable pain other than seek emergency care. If this is the initial incident and no prior diagnosis has been established, it is significant to be observed by a physician.
Potential For Early Cancer Diagnosis Technique
A team led by a Northwestern University biomedical engineer has developed a new optical technique that holds promise for minimally invasive screening methods for the early diagnosis of cancer. The researchers have shown for the first time that nanoscale changes are present in cells extremely early on in carcinogenesis. Continue reading ...
The International Agency for Research on Cancer (IARC), a division of the World Health Organization (WHO), has released updated cancer death projections in a call to action, asking the government to help fund cancer prevention and research initiatives and international tobacco control policies. According to the report, the burden of cancer doubled globally between 1975 and 2000, and cancer is expected to become the leading cause of death worldwide in 2010. Continue reading ...
"Young men undergoing treatment for cancer often want to know how the disease and its treatment affect their chances of fathering healthy children. Our large-scale study shows that there is a slightly higher risk of deformities, but the actual risk of having a child with deformities is nevertheless extremely low. I think this is good news!" These words are from the cancer physician Olof Stahl, who has studied this issue in his coming dissertation from Lund University in Sweden. Continue reading ...
Dr. De Yang, Senior Scientist of the Cellular Immunology Group at the National Cancer Institute of the National Institutes of Health will present at the 7th Cytokines and Inflammation Conference on January 29-30, 2009 in San Diego, CA. Dr. Yang from the NCI will give a presentation on "Alarmin Regulation of Inflammation and Immunity" on January 30, 2009 at 8:45 on the second morning of the conference. Dr. Continue reading ...
SAN ANTONIO - Investigators are reporting favorable early results using RAD001 (Afinitor) combined with weekly paclitaxel and trastuzumab to treat patients with HER-2 overexpressing metastatic breast cancer who have demonstrated prior resistance to trastuzumab. The results, released here at the 2008 San Antonio Breast Cancer Symposium (SABCS), show that RAD001 combined with trastuzumab and chemotherapy halted tumor growth in 77 percent of patients. Continue reading ...
Michael Karin, Professor of Pharmacology Tumor Growth Invasion and Metastasis at UCSD to Give Keynote Speech at GTCbio's 7th Cytokines and Inflammation Conference on January 29-30, 2009 in San Diego, CA Dr. Continue reading ...
The International Agency for Research on Cancer (IARC), a division of the World Health Organization (WHO), has released updated cancer death projections in a call to action, asking the government to help fund cancer prevention and research initiatives and international tobacco control policies. According to the report, the burden of cancer doubled globally between 1975 and 2000, and cancer is expected to become the leading cause of death worldwide in 2010. Continue reading ...
"Young men undergoing treatment for cancer often want to know how the disease and its treatment affect their chances of fathering healthy children. Our large-scale study shows that there is a slightly higher risk of deformities, but the actual risk of having a child with deformities is nevertheless extremely low. I think this is good news!" These words are from the cancer physician Olof Stahl, who has studied this issue in his coming dissertation from Lund University in Sweden. Continue reading ...
Dr. De Yang, Senior Scientist of the Cellular Immunology Group at the National Cancer Institute of the National Institutes of Health will present at the 7th Cytokines and Inflammation Conference on January 29-30, 2009 in San Diego, CA. Dr. Yang from the NCI will give a presentation on "Alarmin Regulation of Inflammation and Immunity" on January 30, 2009 at 8:45 on the second morning of the conference. Dr. Continue reading ...
SAN ANTONIO - Investigators are reporting favorable early results using RAD001 (Afinitor) combined with weekly paclitaxel and trastuzumab to treat patients with HER-2 overexpressing metastatic breast cancer who have demonstrated prior resistance to trastuzumab. The results, released here at the 2008 San Antonio Breast Cancer Symposium (SABCS), show that RAD001 combined with trastuzumab and chemotherapy halted tumor growth in 77 percent of patients. Continue reading ...
Michael Karin, Professor of Pharmacology Tumor Growth Invasion and Metastasis at UCSD to Give Keynote Speech at GTCbio's 7th Cytokines and Inflammation Conference on January 29-30, 2009 in San Diego, CA Dr. Continue reading ...
Subscribe to:
Posts (Atom)
